Dimitar G Efremov Selected Research

ZAP-70 Protein-Tyrosine Kinase (ZAP 70 Protein Tyrosine Kinase)

12/2007	Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells.
11/2005	Comparison of ZAP-70/Syk mRNA levels with immunoglobulin heavy-chain gene mutation status and disease progression in chronic lymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dimitar G Efremov Research Topics

Disease

31	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 02/2003
11	Neoplasms (Cancer) 01/2021 - 07/2009
6	Leukemia 11/2017 - 12/2010
5	Disease Progression 10/2019 - 06/2005
4	Chromosome Aberrations (Chromosome Abnormalities) 01/2012 - 11/2008
3	Lymphoma (Lymphomas) 01/2018 - 03/2007
3	Autoimmune Diseases (Autoimmune Disease) 01/2013 - 01/2012
2	Trisomy (Trisomies) 01/2020 - 06/2019
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2019 - 01/2019
2	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 10/2016 - 02/2003
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Multiple Myeloma 01/2020
1	Paraproteinemias (Monoclonal Gammopathy) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018
1	Residual Neoplasm 12/2017
1	Lymphoid Leukemia 01/2016
1	beta-Thalassemia (Cooley's Anemia) 01/2015
1	Thalassemia 01/2015
1	Cytopenia 01/2013
1	Rheumatoid Arthritis 04/2009
1	Infections 08/2005
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 02/2003

Drug/Important Bio-Agent (IBA)

9	AntigensIBA 11/2017 - 08/2004
7	Rituximab (Mabthera)FDA Link 01/2018 - 01/2013
5	Biological ProductsIBA 01/2020 - 01/2010
4	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2012 - 11/2005
3	Proteins (Proteins, Gene)FDA Link 11/2019 - 02/2013
3	venetoclaxIBA 11/2019 - 01/2016
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 11/2008
3	Chlorambucil (Leukeran)FDA Link 12/2017 - 01/2013
3	Monoclonal AntibodiesIBA 01/2016 - 01/2013
3	Immunoglobulin Variable RegionIBA 01/2011 - 12/2007
2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 06/2005
2	Agammaglobulinaemia Tyrosine KinaseIBA 10/2019 - 02/2014
2	obinutuzumabIBA 12/2017 - 01/2013
2	AutoantigensIBA 11/2017 - 12/2010
2	Bendamustine Hydrochloride FDA Link 10/2016 - 10/2015
2	ofatumumab FDA Link 01/2016 - 01/2013
2	fludarabineIBA 07/2014 - 11/2008
2	Phosphotransferases (Kinase)IBA 08/2012 - 07/2009
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2012 - 01/2012
2	Syk KinaseIBA 05/2011 - 07/2009
2	Antigen Receptors (Antigen Receptor)IBA 12/2007 - 08/2004
2	ZAP-70 Protein-Tyrosine Kinase (ZAP 70 Protein Tyrosine Kinase)IBA 12/2007 - 11/2005
1	Cyclin-Dependent Kinase 4IBA 01/2021
1	BDA-366IBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	ParaproteinsIBA 01/2020
1	ibrutinibIBA 10/2019
1	Chemokine ReceptorsIBA 10/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2019
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 01/2019
1	Auranofin (Ridaura)FDA Link 01/2019
1	Inositol 1,4,5-TrisphosphateIBA 01/2019
1	Prednisone (Sone)FDA LinkGeneric 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	AntibodiesIBA 01/2018
1	Vincristine (Oncovin)FDA LinkGeneric 01/2018
1	Sirtuin 1IBA 08/2015
1	hemoglobin G CoushattaIBA 01/2015
1	Hemoglobins (Hemoglobin)IBA 01/2015
1	hemoglobin G-SzuhuIBA 01/2015
1	Complement System Proteins (Complement)IBA 01/2014
1	CD20 AntigensIBA 01/2014
1	src-Family KinasesIBA 01/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2013
1	TRU 016IBA 01/2013
1	epratuzumabIBA 01/2013
1	lumiliximabIBA 01/2013
1	galiximabIBA 01/2013
1	SurvivinIBA 08/2012
1	tozasertibIBA 08/2012
1	Interleukin-2 (IL2)IBA 08/2012
1	OligonucleotidesIBA 08/2012
1	Aurora KinasesIBA 08/2012
1	fostamatinibIBA 12/2010
1	CPG-oligonucleotideIBA 09/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2009
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2007
1	Messenger RNA (mRNA)IBA 11/2005
1	Indicators and Reagents (Reagents)IBA 11/2005
1	Alemtuzumab (Campath)FDA Link 08/2005
1	Inosine Triphosphate (ITP)IBA 02/2003

Therapy/Procedure

11	Therapeutics 11/2019 - 08/2005
3	Time-to-Treatment 06/2019 - 01/2010
1	Ligation 02/2014
1	Drug Therapy (Chemotherapy) 11/2008